Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INZ-701 in Adults With ENPP1 Deficiency
NCT04686175Phase 2Completed
- Sponsor
- Inozyme Pharma
- Start
- Nov 2021
- Primary completion
- Oct 2024
- Modality
- Replacement Enzymes, Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 2 trial of INZ-701 in ENPP1 deficiency, sponsored by Inozyme Pharma. Started Nov 2021; status: completed.
02
Drugs
INZ-701
03
Conditions
ENPP1 deficiency
Beyond the preview
Go deeper on NCT04686175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686175.